Use of ReDS Technology in Patients With Acute Heart Failure
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04305717 |
Recruitment Status :
Recruiting
First Posted : March 12, 2020
Last Update Posted : February 21, 2021
|
Sponsor:
Icahn School of Medicine at Mount Sinai
Information provided by (Responsible Party):
Donna Mancini, Icahn School of Medicine at Mount Sinai
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Results Submitted - Quality Control (QC) Review Has Not Concluded
Results information for an applicable clinical trial (ACT) is posted within 30 days of
submission even if the submission has not completed the
ClinicalTrials.gov Results Quality Control (QC) review process.
Results information is submitted to ClinicalTrials.gov by the sponsor or investigator,
and National Library of Medicine (NLM) staff assess for apparent errors, deficiencies, or inconsistencies. NLM staff
do not verify the scientific validity or relevance of the submitted information.
All versions of ACT results information submissions that have not completed the QC review process are posted on ClinicalTrials.gov (since January 2020). After the QC review process is completed, the results information is posted without QC review comments and previous versions are archived.
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | December 2021 |
Estimated Study Completion Date : | December 2021 |
Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
---|---|---|
1 |
September 28, 2023 | October 18, 2023 Submission with QC Comments |
2 |
October 19, 2023 | November 8, 2023 Submission with QC Comments |
Publications:
Barghash MH, Lala A, Giustino G, Parikh A, Ullman J, Mitter SS, et al. Use of Remote Dielectric Sensing (ReDS) as Point-of-Care Testing Following Heart Failure Hospitalization and Risk of 30-Day Readmission. J Hear Lung Transplant. 2019;38(4):S140-1